---
figid: PMC6094610__mmt-02-199-g1
figlink: /pmc/articles/PMC6094610/figure/F0001/
number: <b>Figure 1.</b>
caption: Activation of the MAPK pathway due to mutations in BRAF leads to increased
  proliferation and survival of melanoma cells. This growth pathway can be disrupted
  by targeted agents such as BRAF and MEK inhibitors.
pmcid: PMC6094610
papertitle: Dabrafenib and its use in the treatment of metastatic melanoma.
reftext: Samantha Bowyer, et al. Melanoma Manag. 2015 Aug;2(3):199-208.
pmc_ranked_result_index: '27091'
pathway_score: 0.9594967
filename: mmt-02-199-g1.jpg
figtitle: Dabrafenib and its use in the treatment of metastatic melanoma
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6094610__mmt-02-199-g1.html
  '@type': Dataset
  description: Activation of the MAPK pathway due to mutations in BRAF leads to increased
    proliferation and survival of melanoma cells. This growth pathway can be disrupted
    by targeted agents such as BRAF and MEK inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - MAP2K1
  - NRAS
  - MAPK3
  - MAP2K2
  - KRAS
  - HRAS
  - MAPK1
  - Trametinib
  - Dabrafenib
  - Cobimetinib
  - Binimetinib
  - tyrosine
genes:
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Cobimetinib
  source: MESH
  identifier: C574276
- word: Binimetinib
  source: MESH
  identifier: C581313
- word: tyrosine
  source: MESH
  identifier: D014443
diseases: []
---
